Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,265
archived clinical trials in
Crohns Disease

Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Jacksonville, FL
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Atlanta, GA
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Chicago, IL
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Oak Lawn, IL
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
New Orleans, LA
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Boston, MA
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
St. Paul, MN
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
St. Paul, MN
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Mays Landing, NJ
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Mays Landing, NJ
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Morristown, NJ
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Morristown, NJ
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Buffalo, NY
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Greenville, NC
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Greenville, NC
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Nashville, TN
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Houston, TX
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Milwaukee, WI
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule Endoscopy
Open Label Investigator Initiated, Single Site Study of Mucosal Healing in Patients With Small Bowel Crohn's Disease Treated With Certolizumab Pegol (Cimzia) Assessed by Wireless Capsule Endoscopy
Status: Enrolling
Updated:  4/23/2014
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule Endoscopy
Open Label Investigator Initiated, Single Site Study of Mucosal Healing in Patients With Small Bowel Crohn's Disease Treated With Certolizumab Pegol (Cimzia) Assessed by Wireless Capsule Endoscopy
Status: Enrolling
Updated: 4/23/2014
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
ACRI - Phase 1, LLC
mi
from
Anaheim, CA
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
ACRI - Phase 1, LLC
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Advanced Clinical Research Institute - Phase 1, LLC
mi
from
Anaheim, CA
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Advanced Clinical Research Institute - Phase 1, LLC
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
AGMG Endoscopy Center
mi
from
Anaheim, CA
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
AGMG Endoscopy Center
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Alliance Clinical Resarch
mi
from
Oceanside, CA
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Alliance Clinical Resarch
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Alliance Clinical Research, LLC
mi
from
Poway, CA
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Alliance Clinical Research, LLC
mi
from
Poway, CA
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Sharp Rees-Stealy Medical Group, Inc.
mi
from
San Diego, CA
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Sharp Rees-Stealy Medical Group, Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Sharp Rees-Stealy Medical Group, Inc.
mi
from
San Diego, CA
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Sharp Rees-Stealy Medical Group, Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Clinical Research of the Rockies
mi
from
LaFayette, CO
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Clinical Research of the Rockies
mi
from
LaFayette, CO
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Endoscopy Center of the Rockies - Longmont
mi
from
Longmont, CO
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Endoscopy Center of the Rockies - Longmont
mi
from
Longmont, CO
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Endoscopy Center of Connecticut, LLC
mi
from
Guilford, CT
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Endoscopy Center of Connecticut, LLC
mi
from
Guilford, CT
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Endoscopy Center of Connecticut, LLC
mi
from
Hamden, CT
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Endoscopy Center of Connecticut, LLC
mi
from
Hamden, CT
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Gastroenterology Center of Connecticut
mi
from
Hamden, CT
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Gastroenterology Center of Connecticut
mi
from
Hamden, CT
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Medical Research Center of Connecticut, LLC
mi
from
Hamden, CT
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Medical Research Center of Connecticut, LLC
mi
from
Hamden, CT
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Clinical Research of West Florida
mi
from
Clearwater, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Clinical Research of West Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Gasteroenterology Consultants of Clearwater
mi
from
Clearwater, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Gasteroenterology Consultants of Clearwater
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
West Coast Endoscopy Center
mi
from
Clearwater, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
West Coast Endoscopy Center
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Citrus Surgery & Endoscopy Center (Colonoscopy & Biopsy Only)
mi
from
Crystal River, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Citrus Surgery & Endoscopy Center (Colonoscopy & Biopsy Only)
mi
from
Crystal River, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Drug Shipment Address
mi
from
Gainesville, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Drug Shipment Address
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Shands Endoscopy Center
mi
from
Gainesville, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Shands Endoscopy Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
University of Florida College of Medicine
mi
from
Gainesville, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
University of Florida College of Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Shands Medical Plaza and Cancer Institute
mi
from
Gainsville, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Shands Medical Plaza and Cancer Institute
mi
from
Gainsville, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Nature Coast Clinical Research
mi
from
Inverness, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Nature Coast Clinical Research
mi
from
Inverness, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Suncoast Endoscopy Center (Colonoscopy Only)
mi
from
Inverness, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Suncoast Endoscopy Center (Colonoscopy Only)
mi
from
Inverness, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Center for Advanced Gastroenterology
mi
from
Maitland, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Center for Advanced Gastroenterology
mi
from
Maitland, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
MNH Surgical Center
mi
from
Maitland, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
MNH Surgical Center
mi
from
Maitland, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
FQL Research, LLC
mi
from
Miramar, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
FQL Research, LLC
mi
from
Miramar, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Gastroenterology Group of Naples
mi
from
Naples, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Gastroenterology Group of Naples
mi
from
Naples, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
North Florida Gastroenterology Research, LLC
mi
from
Orange Park, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
North Florida Gastroenterology Research, LLC
mi
from
Orange Park, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Internal Medicine Specialists
mi
from
Orlando, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Internal Medicine Specialists
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Florida Medical Clinic, PA
mi
from
Zephyrhills, FL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Florida Medical Clinic, PA
mi
from
Zephyrhills, FL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Southwest Gastroenterology
mi
from
Oak Lawn, IL
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Southwest Gastroenterology
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Heartland Medical Research, Inc (Administrative Only)
mi
from
Clive, IA
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Heartland Medical Research, Inc (Administrative Only)
mi
from
Clive, IA
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Iowa Digestive Disease Center
mi
from
Clive, IA
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Iowa Digestive Disease Center
mi
from
Clive, IA
Click here to add this to my saved trials
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated:  2/13/2015
Iowa Endoscopy Center (Colonoscopy Only)
mi
from
Clive, IA
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study To Investigate The Safety And Efficacy Of Cp-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling
Updated: 2/13/2015
Iowa Endoscopy Center (Colonoscopy Only)
mi
from
Clive, IA
Click here to add this to my saved trials